Detail Data
Volume (24h): 216,621 shares
P/E Ratio: /
Forward P/E: /
EPS: -0.01 USD
Forward EPS: /
Number of Shares: 304,851,008 shares
Market Capitalization: 62,829,792.00 USD

Dividend

Dividend Value
Dividend Amount According to our data, the company BioLargo does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: 1997-05-28
5-Year Avg Yield %: -
Payout Ratio: -
Last Dividend Value: -
Last Dividend Date: -

Analyst Forecast

Most analysts have issued a none recommendation for BioLargo stock. The current number of analysts covering this company is 1. The highest target price is 0.35 USD, while the lowest target price is 0.35 USD. The median target valuation set by analysts is 0.35 USD. These forecasts and recommendations provide insight into how analysts view the future stock performance of BioLargo.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for BioLargo stock is: none
Number of Analysts: 1
Highest Target Price: 0.35 USD
Lowest Target Price: 0.35 USD
Median Target Price: 0.35 USD

Fundamental Indicators

Indicator Data
Total Revenue: 16,288,000.00 USD
Net Income: -3,147,000.00 USD
Price-to-Book (P/B): 8.24
PEG Ratio: /
Exchange: OTC Markets OTCQX
Industry: Chemicals
Sector: Basic Materials
Number of Employees: 40
Country: United States

Where to Buy BioLargo Stock?

You can purchase BioLargo stock on the OTC Markets OTCQX under the ticker symbol: BLGO. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on BioLargo Stock

Indicator Value
Company Revenue: 16,288,000.00 USD
EBITDA: -5,234,000.00 USD - Negative EBITDA may signal financial challenges or growth investments.
Earnings Per Share: -0.01 USD
Book Value Per Share: 0.03 USD
Total Cash: 2,564,000.00 USD
Total Cash per Share: 0.01 USD
Total Debt: 3,053,000.00 USD
Debt to Equity Ratio: 0.60
Quick Ratio 2.01
Current Ratio 2.14
Free Cash Flow -3,314,500.00 USD
Operating Cash Flow -5,517,000.00 USD
Gross Margins 43.56 %
EBITDA Margins -32.13 %
Operating Margins -56.96 %
Profit Margins -19.32 %
Return on Assets -33.4 %
Return on Equity -107.3 %
Earnings Growth (1 year) -
Revenue Growth (1 year) -31.3 %
Quarterly Earnings Year-over-Year Growth -
Market Capitalization 62,829,792.00 USD
Enterprise Value 61,566,560.00 USD
EV/Revenue 3.78
EV/EBITDA -11.763
Float Shares 260,870,069 shares
Shares Outstanding 304,851,008 shares
Held Percent Insiders 0.14 %
Held Percent Institutions 0.04 %
Shares Short -
Shares Short Prior Month -
Date Short Interest -
Short Percentage of Total Shares -
Short Ratio -
Beta 0.13
Short Percentage of Float -
Implied Shares Outstanding 304,851,008

Frequently Asked Questions (FAQ)

According to our data, the company BioLargo does not pay dividends yet, even in 2025.

BioLargo shares are traded on the OTC Markets OTCQX stock exchange under the ticker: BLGO. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

According to our data, the recommendation for BioLargo shares is from a total of 1 analysts. The average target price prediction is 0.35 USD per share.

The total number of BioLargo shares on the exchange is 304,851,008.00 shares, which at the current market capitalization gives the company a total valuation of 62,829,792.00 USD.